title: Behavioral differentiation between itch and pain in mouse.
abstract: The standard rodent model of itch uses scratching with the hind limb as a behavioral response to pruritic stimuli applied to the nape of the neck. The assumption is that scratching is an indicator of the sensation of itch. But because only one type of site-directed behavior is available, one cannot be certain that scratching is not a response to nociceptive or other qualities of sensations in addition to, or instead of, itch. To extend the model, we administered chemical stimuli to the cheek of the mouse and counted scratching with the hind limb as an indicator of itch and wiping with the forelimb as an indicator of pain. An intradermal injection of histamine and capsaicin, known to evoke predominantly itch and pain, respectively, in humans, each elicited hind limb scratching behavior when injected into the nape of the neck of the mouse. In contrast, when the same chemicals were injected into the cheek of the mouse, there were two site-directed behaviors: histamine again elicited scratching with the hind limb, but capsaicin evoked wiping with the forelimb. We conclude that the "cheek model of itch" in the mouse provides a behavioral differentiation of chemicals that elicit predominantly itch in humans from those that evoke nociceptive sensations. That is, the model provides a behavioral differentiation between itch and pain in the mouse.
authors.affiliation: Department of Anesthesiology, Yale University School of Medicine, P.O. Box 208051, 333 Cedar Street, New Haven, Connecticut 06520-8051, USA.
authors.forename: Steven G
authors.initials: SG
authors.lastname: Shimada
authors.forename: Robert H
authors.initials: RH
authors.lastname: LaMotte
mesh_terms: D000818:Animals; D001522:Behavior, Animal; D002211:Capsaicin / Q000008:administration & dosage / Q000633:toxicity; D002610:Cheek; D004305:Dose-Response Relationship, Drug; D005552:Forelimb / Q000503:physiopathology; D006614:Hindlimb / Q000503:physiopathology; D006632:Histamine / Q000008:administration & dosage / Q000633:toxicity; D008297:Male; D051379:Mice; D010146:Pain / Q000139:chemically induced / Q000503:physiopathology*; D011537:Pruritus / Q000139:chemically induced / Q000503:physiopathology*
chemical_list: D006632:Histamine; D002211:Capsaicin
references.citation: Pain. 1993 Jun;53(3):323-334
references.pmid: 8351161
references.citation: Pain. 2006 Sep;124(1-2):50-8
references.pmid: 16697529
references.citation: Pain. 1989 Jul;38(1):99-107
references.pmid: 2780068
references.citation: Br J Pharmacol. 2004 Apr;141(7):1118-30
references.pmid: 15006899
references.citation: Eur J Pharmacol. 2006 Jan 20;530(3):281-3
references.pmid: 16356490
references.citation: Pain. 1983 Jun;16(2):109-110
references.pmid: 6877845
references.citation: Skin Pharmacol Appl Skin Physiol. 2001 Mar-Apr;14(2):87-96
references.pmid: 11316967
references.citation: Somatosens Res. 1987;5(2):81-92
references.pmid: 3423533
references.citation: Anesthesiology. 1999 Sep;91(3):617-25
references.pmid: 10485769
references.citation: Exp Brain Res. 2008 Jan;184(3):435-8
references.pmid: 18030453
references.citation: Eur J Pharmacol. 1995 Mar 14;275(3):229-33
references.pmid: 7539379
references.citation: Pain. 2004 Nov;112(1-2):148-55
references.pmid: 15494195
references.citation: J Neurophysiol. 2003 May;89(5):2441-8
references.pmid: 12611975
references.citation: Int Immunopharmacol. 2004 Jan;4(1):101-8
references.pmid: 14975364
references.citation: Pain. 1998 May;76(1-2):173-8
references.pmid: 9696471
references.citation: J Neurosci. 2008 Apr 23;28(17):4331-5
references.pmid: 18434511